Tibet Cheezheng Tibetan Medicine Co Ltd Cash Flow-to-Debt Ratio
Tibet Cheezheng Tibetan Medicine Co Ltd cash flow-to-debt ratio. Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥34.69 Million could theoretically repay 0% of its total liabilities (CN¥1.78 Billion) in one year. Check 002287 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Cash flow-to-debt ratio of Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2025. Historical debt coverage capacity for Tibet Cheezheng Tibetan Medicine Co Ltd across 20 annual periods. Check 002287 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Tibet Cheezheng Tibetan Medicine Co Ltd Cash Flow-to-Debt Ratio by Year (2006–2025)
Tibet Cheezheng Tibetan Medicine Co Ltd cash flow-to-debt ratio by year from 2006 to 2025. Year-by-year debt coverage analysis for Tibet Cheezheng Tibetan Medicine Co Ltd. For the full cash flow conversion analysis, see Tibet Cheezheng Tibetan Medicine Co Ltd operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | CN¥729.70 Million | CN¥1.92 Billion | ▲ +122.7% |
| 2024 | 0.17x | CN¥456.75 Million | CN¥2.68 Billion | ▼ -37.8% |
| 2023 | 0.27x | CN¥693.41 Million | CN¥2.53 Billion | ▲ +139.9% |
| 2022 | 0.11x | CN¥285.69 Million | CN¥2.50 Billion | ▼ -74.1% |
| 2021 | 0.44x | CN¥1.03 Billion | CN¥2.35 Billion | ▲ +237.1% |
| 2020 | 0.13x | CN¥238.65 Million | CN¥1.82 Billion | ▼ -76.7% |
| 2019 | 0.56x | CN¥405.95 Million | CN¥722.20 Million | ▼ -69.9% |
| 2018 | 1.87x | CN¥499.40 Million | CN¥267.54 Million | ▲ +227.1% |
| 2017 | 0.57x | CN¥229.83 Million | CN¥402.78 Million | ▼ -52.4% |
| 2016 | 1.20x | CN¥389.20 Million | CN¥324.33 Million | ▲ +95.0% |
| 2015 | 0.62x | CN¥257.81 Million | CN¥419.05 Million | ▼ -52.1% |
| 2014 | 1.28x | CN¥310.95 Million | CN¥242.20 Million | ▼ -44.2% |
| 2013 | 2.30x | CN¥198.48 Million | CN¥86.34 Million | ▲ +9.6% |
| 2012 | 2.10x | CN¥169.67 Million | CN¥80.90 Million | ▲ +1529.7% |
| 2011 | -0.15x | CN¥-11.74 Million | CN¥80.01 Million | ▼ -116.8% |
| 2010 | 0.88x | CN¥96.91 Million | CN¥110.72 Million | ▼ -23.9% |
| 2009 | 1.15x | CN¥175.58 Million | CN¥152.68 Million | ▲ +72.7% |
| 2008 | 0.67x | CN¥65.93 Million | CN¥99.02 Million | ▼ -13.8% |
| 2007 | 0.77x | CN¥91.43 Million | CN¥118.37 Million | ▲ +169.6% |
| 2006 | 0.29x | CN¥38.50 Million | CN¥134.37 Million | — |